• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

BUSPIRONE Drug Record

  • Summary
  • Interactions
  • Claims
  • BUSPIRONE chembl:CHEMBL49 Approved

    Alternate Names:

    BUSPAR
    BCI-024
    BUSPIRONE
    BUSPAR®
    MJ-9022-1
    BUSPIRON
    BUSPIRONA
    BUSPIRONUM
    8-(4-(4-(2-PYRIMIDINYL)-1-PIPERIZINYL)BUTYL)-8-AZASPIRO(4,5)DECANE-7,9-DIONE
    rxcui:1827
    drugbank:00490
    chembl:CHEMBL49
    pubchem.compound:2477
    chemidplus:36505-84-7

    Drug Info:

    Year of Approval 1986
    Drug Class anti-anxiety agents
    FDA Approval 1986
    Drug Class small molecule
    Drug Indications Anti-anxiety Agents
    (3 More Sources)

    Publications:

    Coccaro et al., 1990, Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans., Psychopharmacol Bull
    Pache et al., 2003, Buspirone differentially modifies short-term memory function in a combined delayed matching/non-matching to position task., Eur. J. Pharmacol.
    Nader et al., 1993, Interactions of buspirone or gepirone with nicotine on schedule-controlled behavior of pigeons., Behav Pharmacol
    Malt et al., 2003, Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls., J Affect Disord
    Boido et al., 2001, Synthesis and pharmacological evaluation of aryl/heteroaryl piperazinyl alkyl benzotriazoles as ligands for some serotonin and dopamine receptor subtypes., Farmaco
    Fernández-Pérez et al., 2005, Co-administration of fluoxetine and WAY100635 improves short-term memory function., Eur. J. Pharmacol.
    Rehman et al., 1999, Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor., Brain Res.
    Liang, 1999, Pre- or post-training injection of buspirone impaired retention in the inhibitory avoidance task: involvement of amygdala 5-HT1A receptors., Eur. J. Neurosci.
    Dupuis et al., 1999, Modulation of 5-HT1A receptor signalling by point-mutation of cysteine351 in the rat Galpha(o) protein., Neuropharmacology
    Osei-Owusu et al., 2004, Buspirone raises blood pressure through activation of sympathetic nervous system and by direct activation of alpha1-adrenergic receptors after severe hemorrhage., J. Pharmacol. Exp. Ther.
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Becker et al., 1999, Prevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat., Neuropharmacology
    de Boer et al., 1999, Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635., J. Pharmacol. Exp. Ther.
    Zanger UM et al., 2008, Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation., Anal Bioanal Chem
  • BUSPIRONE   HTR1A

    Interaction Score: 1.58

    Interaction Types & Directionality:
    partial agonist (activating)
    agonist (activating)

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    PMIDs:
    10064829 10215901 10428422 14769835 11752352 10221756 10027850


    Sources:
    TdgClinicalTrial TEND TTD

  • BUSPIRONE   PRL

    Interaction Score: 0.54

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    2274641


    Sources:
    NCI

  • BUSPIRONE   DRD2

    Interaction Score: 0.37

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    PMIDs:
    14522358 11224194 12781354 11421254 16214127


    Sources:
    TdgClinicalTrial TEND

  • BUSPIRONE   CYP3A5

    Interaction Score: 0.17

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    18695978


    Sources:
    PharmGKB

  • BUSPIRONE   ALDH1A1

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BUSPIRONE   NFE2L2

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BUSPIRONE   EHMT2

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TEND: BUSPIRONE

    • Version: 01-August-2011

    Alternate Names:
    BUSPIRONE Primary Drug Name

    Drug Info:
    Drug Class anti-anxiety agents
    Year of Approval 1986

    Publications:

  • TdgClinicalTrial: BUSPIRONE

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Anti-anxiety Agents
    Drug Class small molecule
    FDA Approval 1986

    Publications:

  • NCI: BUSPIRONE

    • Version: 14-September-2017

    Alternate Names:
    C26641 NCI drug code

    Drug Info:

    Publications:
    Coccaro et al., 1990, Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans., Psychopharmacol Bull

  • PharmGKB: buspirone

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Zanger UM et al., 2008, Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation., Anal Bioanal Chem

  • TTD: Buspirone

    • Version: 2020.06.01

    Alternate Names:
    D0U2OO TTD Drug ID

    Drug Info:

    Publications:

  • DTC: BUSPIRONE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL49 ChEMBL Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL49

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21